S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
France must raise pension age to 64, prime minister says
The Next Big Crisis Is Here (Ad)
Qatar replaces Russian company in Lebanon gas exploration
Elon Musk's mysterious ways on display in Tesla tweet trial
The Next Big Crisis Is Here (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
France must raise pension age to 64, prime minister says
The Next Big Crisis Is Here (Ad)
Qatar replaces Russian company in Lebanon gas exploration
Elon Musk's mysterious ways on display in Tesla tweet trial
The Next Big Crisis Is Here (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
France must raise pension age to 64, prime minister says
The Next Big Crisis Is Here (Ad)
Qatar replaces Russian company in Lebanon gas exploration
Elon Musk's mysterious ways on display in Tesla tweet trial
The Next Big Crisis Is Here (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
France must raise pension age to 64, prime minister says
The Next Big Crisis Is Here (Ad)
Qatar replaces Russian company in Lebanon gas exploration
Elon Musk's mysterious ways on display in Tesla tweet trial
The Next Big Crisis Is Here (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
NASDAQ:CGEM

Cullinan Oncology - CGEM Price Target & Analyst Ratings

$11.47
+0.32 (+2.87%)
(As of 01/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$11.07
$11.58
50-Day Range
$9.72
$13.41
52-Week Range
$7.30
$15.89
Volume
114,101 shs
Average Volume
120,121 shs
Market Capitalization
$523.15 million
P/E Ratio
5.17
Dividend Yield
N/A
Price Target
$50.00

Cullinan Oncology Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Buy
Based on 3 Analyst Ratings

Consensus Analyst Price Target

$50.00
335.92% Upside
High Prediction$50.00
Average Prediction$50.00
Low Prediction$50.00
TypeCurrent
1/29/22 to 1/29/23
1 Month Ago
12/30/21 to 12/30/22
3 Months Ago
10/31/21 to 10/31/22
1 Year Ago
1/29/21 to 1/29/22
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
2 Buy rating(s)
4 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$50.00$50.00$52.00$51.75
Predicted Upside335.92% Upside322.65% Upside247.98% Upside70.22% Upside
Get Cullinan Oncology Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CGEM and its competitors with MarketBeat's FREE daily newsletter.


CGEM Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CGEM Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Cullinan Oncology Stock vs. The Competition

TypeCullinan OncologyMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.64
2.46
Consensus RatingBuyBuyHold
Predicted Upside335.92% Upside1,053.64% Upside9.92% Upside
News Sentiment RatingPositive News
Positive News
Neutral News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/21/2022BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy
5/17/2022HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Edward White
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$50.00+322.65%
2/8/2022SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Berens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
6/7/2021Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$40.00 ➝ $43.00+29.87%
2/2/2021Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$55.00+62.87%
(Data available from 1/29/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












CGEM Price Target - Frequently Asked Questions

What is Cullinan Oncology's consensus rating and price target?

According to the issued ratings of 3 analysts in the last year, the consensus rating for Cullinan Oncology stock is Buy based on the current 3 buy ratings for CGEM. The average twelve-month price prediction for Cullinan Oncology is $50.00 with a high price target of $50.00 and a low price target of $50.00. Learn more on CGEM's analyst rating history.

Do Wall Street analysts like Cullinan Oncology more than its competitors?

Analysts like Cullinan Oncology more than other Medical companies. The consensus rating score for Cullinan Oncology is 3.00 while the average consensus rating score for medical companies is 2.64. Learn more on how CGEM compares to other companies.

Does Cullinan Oncology's stock price have much upside?

According to analysts, Cullinan Oncology's stock has a predicted upside of 322.65% based on their 12-month price targets.

What analysts cover Cullinan Oncology?

Cullinan Oncology has been rated by BTIG Research in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:CGEM) was last updated on 1/29/2023 by MarketBeat.com Staff